These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25692612)

  • 1. Optical coherence tomography appraisal of residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing intraprocedural versus post-stenting prolonged bivalirudin infusion. Rationale and design of the MATRIX (Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and angioX) OCT substudy.
    Picchi A; Limbruno U; Andò G; Brugaletta S; Cortese B; De Carlo M; Garcia-Garcia HM; Palmieri C; Regar E; Rigattieri S; Sardella G; Zimarino M; Valgimigli M
    EuroIntervention; 2015 Mar; 10(11):1311-7. PubMed ID: 25692612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing bivalirudin versus unfractionated heparin infusion: The MATRIX (minimizing adverse hemorrhagic events by transradial access site and angioX) OCT study.
    Garcia-Garcia HM; Adamo M; Soud M; Yacob O; Picchi A; Sardella G; Frigoli E; Limbruno U; Rigattieri S; Diletti R; Boccuzzi G; Zimarino M; Contarini M; Russo F; Calabrò P; Andò G; Varbella F; Garducci S; Palmieri C; Briguori C; Karagiannis A; Valgimigli M
    Catheter Cardiovasc Interv; 2020 Nov; 96(6):1156-1171. PubMed ID: 31883294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of intra-procedural vs. post-stenting prolonged bivalirudin infusion for residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing: the MATRIX (Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and angioX) OCT study.
    Garcia-Garcia HM; Picchi A; Sardella G; Adamo M; Frigoli E; Limbruno U; Rigattieri S; Diletti R; Boccuzzi G; Zimarino M; Contarini M; Russo F; Calabro' P; Andò G; Varbella F; Garducci S; Palmieri C; Briguori C; Kuku KO; Rothenbühler M; Karagiannis A; Valgimigli M
    Eur Heart J Cardiovasc Imaging; 2019 Dec; 20(12):1418-1428. PubMed ID: 30920584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.
    Valgimigli M; Frigoli E; Leonardi S; Vranckx P; Rothenbühler M; Tebaldi M; Varbella F; Calabrò P; Garducci S; Rubartelli P; Briguori C; Andó G; Ferrario M; Limbruno U; Garbo R; Sganzerla P; Russo F; Nazzaro M; Lupi A; Cortese B; Ausiello A; Ierna S; Esposito G; Ferrante G; Santarelli A; Sardella G; de Cesare N; Tosi P; van 't Hof A; Omerovic E; Brugaletta S; Windecker S; Heg D; Jüni P;
    Lancet; 2018 Sep; 392(10150):835-848. PubMed ID: 30153988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-Procedural Bivalirudin Infusion at Full or Low Regimen in Patients With Acute Coronary Syndrome.
    Gargiulo G; Carrara G; Frigoli E; Leonardi S; Vranckx P; Campo G; Varbella F; Calabrò P; Zaro T; Bartolini D; Briguori C; Andò G; Ferrario M; Limbruno U; Colangelo S; Sganzerla P; Russo F; Nazzaro MS; Esposito G; Ferrante G; Santarelli A; Sardella G; Windecker S; Valgimigli M
    J Am Coll Cardiol; 2019 Feb; 73(7):758-774. PubMed ID: 30784669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of postprocedural full-dose infusion of bivalirudin on acute stent thrombosis in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Outcomes in a large real-world population.
    Wang H; Liang Z; Li Y; Li B; Liu J; Hong X; Lu X; Wu J; Zhao W; Liu Q; An J; Li L; Pu F; Ming Q; Han Y
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28083915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OCT Appraisal of Residual Thrombus Burden in Patients With STEMI Undergoing Intraprocedural Versus Post-Stenting Prolonged Bivalirudin Infusion: The MATRIX OCT Study.
    Picchi A; Garcia-Garcia HM; Sardella G; Adamo M; Frigoli E; Limbruno U; Rigattieri S; Diletti R; Boccuzzi G; Zimarino M; Contarini M; Russo F; Calabro P; Andò G; Varbella F; Garducci S; Palmieri C; Briguori C; Kuku KO; Rothenbühler M; Karagiannis A; Valgimigli M
    JACC Cardiovasc Imaging; 2019 May; 12(5):934-936. PubMed ID: 30660538
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolonged High-Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary Percutaneous Coronary Intervention: Novel Insights From an Updated Meta-Analysis.
    Fahrni G; Wolfrum M; De Maria GL; Banning AP; Benedetto U; Kharbanda RK
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27451466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bivalirudin in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: outcomes in a large real-world population.
    Shelton R; Eftychiou C; Somers K; Liu A; Burton-Wood N; Anderson M; Makri L; Blaxill J; McLenachan J; Wheatcroft S; Greenwood J; Blackman D
    EuroIntervention; 2013 May; 9(1):118-24. PubMed ID: 23410540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and rationale for the Minimizing Adverse haemorrhagic events by TRansradial access site and systemic Implementation of angioX program.
    Valgimigli M;
    Am Heart J; 2014 Dec; 168(6):838-45.e6. PubMed ID: 25458646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between post-percutaneous coronary intervention bivalirudin infusion and net adverse clinical events: a post hoc analysis of the GLOBAL LEADERS study.
    Chang CC; Chichareon P; Modolo R; Takahashi K; Kogame N; Tomaniak M; Gao C; Royaards KJ; Cequier A; Oldroyd K; Steg PG; Hamm C; Jüni P; Valgimigli M; Windecker S; Onuma Y; Stables RH; Jan van Geuns R; Serruys PW
    Eur Heart J Cardiovasc Pharmacother; 2020 Jan; 6(1):22-30. PubMed ID: 31841136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of post-primary percutaneous coronary intervention bivalirudin infusion on net adverse clinical events and mortality: A comprehensive pairwise and network meta-analysis of randomized controlled trials.
    Shah R; Matin K; Rogers KC; Rao SV
    Catheter Cardiovasc Interv; 2017 Aug; 90(2):196-204. PubMed ID: 27862911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute kidney injury after percutaneous coronary intervention: Rationale of the AKI-MATRIX (acute kidney injury-minimizing adverse hemorrhagic events by TRansradial access site and systemic implementation of angioX) sub-study.
    Andò G; Cortese B; Frigoli E; Gagnor A; Garducci S; Briguori C; Rubartelli P; Calabrò P; Valgimigli M;
    Catheter Cardiovasc Interv; 2015 Nov; 86(5):950-7. PubMed ID: 25854692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracoronary Bivalirudin Bolus in ST-Elevation Myocardial Infarction Patients Treated with Primary Angioplasty: Theoretical Bases, Clinical Experience, and Future Applications.
    Lupi A; Schaffer A; Rognoni A; Cavallino C; Bongo AS; Cortese B; Jaffe AS; Angiolillo DJ; Porto I
    Am J Cardiovasc Drugs; 2016 Dec; 16(6):391-397. PubMed ID: 27541144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Post-Primary Percutaneous Coronary Intervention Bivalirudin Infusion on Acute Stent Thrombosis: Meta-Analysis of Randomized Controlled Trials.
    Shah R; Rogers KC; Ahmed AJ; King BJ; Rao SV
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1313-20. PubMed ID: 27318846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Culprit lesion thrombus burden after manual thrombectomy or percutaneous coronary intervention-alone in ST-segment elevation myocardial infarction: the optical coherence tomography sub-study of the TOTAL (ThrOmbecTomy versus PCI ALone) trial.
    Bhindi R; Kajander OA; Jolly SS; Kassam S; Lavi S; Niemelä K; Fung A; Cheema AN; Meeks B; Alexopoulos D; Kočka V; Cantor WJ; Kaivosoja TP; Shestakovska O; Gao P; Stankovic G; Džavík V; Sheth T
    Eur Heart J; 2015 Aug; 36(29):1892-900. PubMed ID: 25994742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and repeatability of optical coherence tomography measurements of pre-stent thrombus burden in patients with STEMI treated with primary PCI.
    Kajander OA; Koistinen LS; Eskola M; Huhtala H; Bhindi R; Niemelä K; Jolly SS; Sheth T;
    Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):96-107. PubMed ID: 25240168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two hour bivalirudin infusion after PCI for ST elevation myocardial infarction.
    Anderson PR; Gogo PB; Ahmed B; Straight F; Terrien EF; Watkins MW; El Gharib N; Dauerman HL
    J Thromb Thrombolysis; 2011 May; 31(4):401-6. PubMed ID: 21107655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of optical coherence tomography findings on clinical outcomes in ST-segment elevation myocardial infarction patients: a MATRIX (Minimizing Adverse Hemorrhagic Events by Trans-radial Access Site and angioX) OCT sub-study.
    Yacob O; Garcia-Garcia HM; Dan K; Soud M; Adamo M; Picchi A; Sardella G; Frigoli E; Limbruno U; Rigattieri S; Diletti R; Boccuzzi G; Zimarino M; Contarini M; Russo F; Calabro P; Ando G; Varbella F; Garducci S; Palmieri C; Briguori C; Kuku KO; Karagiannis A; Valgimigli M
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1143-1150. PubMed ID: 33225426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and design of the INFUSE-AMI study: A 2 × 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction.
    Gibson CM; Maehara A; Lansky AJ; Wohrle J; Stuckey T; Dave R; Cox D; Grines C; Dudek D; Steg G; Parise H; Wolff SD; Cristea E; Stone GW
    Am Heart J; 2011 Mar; 161(3):478-486.e7. PubMed ID: 21392601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.